Keefe, Bruyette & Woods Upgrades CME Group to Outperform, Maintains Price Target to $305

Benzinga Newsdesk www.benzinga.com Positive 81.9%

Neg 0% Neu 0% Pos 81.9%

Keefe, Bruyette & Woods analyst Chris Allen upgrades CME Group (NASDAQ:CME) from Market Perform to Outperform and maintains the price target from $305 to $305.